Home Newsfeeds JP Morgan Downgrades Bioventus to Underweight

JP Morgan Downgrades Bioventus to Underweight

JP Morgan analyst Robbie Marcus downgrades Bioventus (NASDAQ:BVS) from Overweight to Underweight.

byBenzinga Newsdesk

November 9, 2022

1 minute read

JP Morgan analyst Robbie Marcus downgrades Bioventus (NASDAQ:BVS) from Overweight to Underweight.

EF Hutton Initiates Coverage On GT Biopharma with Hold Rating, Announces Price Target of $2

By Benzinga Newsdesk

January 5, 5:30 AM

EF Hutton analyst Tony Butler initiates coverage on GT Biopharma (NASDAQ:GTBP) with a Hold rating and announces Price Target of $2.

GTBP

Airline Passenger Rights Elevated: Biden Administration Enforces Refund Rule

By Shivani Kumaresan

April 24, 2:03 PM

Biden-Harris Administration Introduces Rule for Swift Airline Refunds: DOT mandates automatic cash refunds for flight cancellations, delays, and schedule changes, streamlining passenger compensation process.

AAL

Mark Cuban To Release His Book As NFT On Polygon Network This Week

By Mehab Qureshi

June 4, 11:42 PM

Entrepreneur and television personality Mark Cuban is set to release his book titled “How to Win at the Sport of Business: If I Can Do It, You Can Do It”, this week as an NFT using the Polygon (CRYPTO: MATIC) network.

$MATIC

Kimball International Q4 EPS $0.24 Beats $0.11 Estimate, Sales $176.95M Miss $182.70M Estimate

By Benzinga Newsdesk

August 4, 7:20 PM

Kimball International (NASDAQ:KBAL) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.11 by 118.18 percent. This is a 300 percent increase over earnings of $0.06 per share

KBAL

JP Morgan Downgrades Bioventus to Underweight

Related Posts

EF Hutton Initiates Coverage On GT Biopharma with Hold Rating, Announces Price Target of $2

Airline Passenger Rights Elevated: Biden Administration Enforces Refund Rule

Mark Cuban To Release His Book As NFT On Polygon Network This Week

Kimball International Q4 EPS $0.24 Beats $0.11 Estimate, Sales $176.95M Miss $182.70M Estimate